Conquering Postprandial Spikes: Siab -Purity Insulin Aspart API (CAS 116094-23-6)
Aug 16, 2026
Tso lus
Engineering the Prandial Spike: Siab -Fidelity Insulin Aspart API (CAS 116094-23-6)
Kev Tshawb Fawb R & D ntawm Electrostatic Repulsion, Monomeric Dissociation, thiab Rapid-Ua Recombinant Peptide Synthesis.
Cov kev kho mob qub txeeg qub teg, xws li Regular Human Insulin (RHI), cov txheej txheem tiv thaiv kev nqus sai. Vim lawv txoj kev nyiam ua kom nruj nruj hexamers nyob rau hauv qhov chaw subcutaneous, RHI yuav tsum tau 30 mus rau 45 feeb ua ntej- noj mov, ua rau cov neeg mob ua raws li cov neeg mob tsis zoo thiab tsis sib haum xeeb glycemic nkhaus.Insulin Aspart (CAS 116094-23-6)tag rewrote cov cai ntawm kev tswj noj mov. Los ntawm engineering ib leeg, tshwj xeeb amino acid hloov pauv, cov neeg tsim khoom tsim cov molecule uas tawg nws tus kheej cov qauv kev ruaj ntseg thaum txhaj tshuaj, ua tiav cov ntshav -cov piam thaj txo qis hauv 10 mus rau 15 feeb. Cov ntaub ntawv thev naus laus zis no nthuav tawm cov khoom siv hluav taws xob ntawm lub cev ntawm ProB28Asp hloov pauv, tshawb nrhiav cov kev hloov pauv ntawm kev ua kom tsis tu ncua subcutaneous infusion, thiab qhia txog cov txheej txheem kev tsim khoom sib xyaw ua ke uas tau ua tiav ntawm Xi'an Tihealth.
1. Molecular Architecture: Engineering Rapid Monomeric Dissociation
Txhawm rau tsim cov tshuaj insulin ntev heev los yog lub twj tso kua mis tso kua dej txhim khu kev qha, pab pawg tsim khoom yuav tsum nkag siab txog kev txwv lub cev ntawm subcutaneous absorption. Insulin yog 51-amino acid polypeptide (C256H381N65O79S6) tsim los ntawm A- saw thiab B- saw txuas los ntawm cov txuas txuas txuas nrog disulfide. Hauv kev lag luam vials, nws ruaj khov li hexamer nyob ib ncig ntawm zinc ions (Zn2+). Txawm li cas los xij, capillaries tsuas tuaj yeem nqus cov tshuaj insulin monomers nkaus xwb. Kev kho mob qeeb ntawm cov tshuaj insulin ib txwm yog tshwm sim los ntawm kev qeeb qeeb ntawm cov hexamers no.
ProB28Asp Hloov Chaw: Ua kom tsis muaj kev cuam tshuam
Insulin Aspart muab nws cov khoom sai sai - ua yeeb yam los ntawm ib qho lus, masterfully tsom homologous hloov kho. Hauv tib neeg cov tshuaj insulin ib ntus, cov amino acid ntawm txoj hauj lwm 28 ntawm B- saw yog proline. Hauv Insulin Aspart, qhov proline no tau hloov pauv nrog aspartic acid. Qhov kev hloov pauv no qhia txog qhov tsis zoo uas tsis zoo, cov saw hlau sab hauv hydrophilic rau hauv thaj av uas ib txwm koom nrog dimer-dimer kev sib cuam tshuam.
Electrostatic Repulsion & Steric Hindrance
Kev taw qhia ntawm aspartic acid ua rau muaj kev cuam tshuam loj steric thiab khaus electrostatic repulsion ntawm qhov sib cuam tshuam ntawm tus neeg monomer units. Txawm hais tias cov molecule tseem tuaj yeem raug yuam mus rau hauv lub xeev hexameric ruaj khov hauv cov tshuaj vial siv cov zinc thiab phenolic preservatives siab, cov qauv no yog qhov tsis ruaj khov thaum raug rau lub cev ib puag ncig. Thaum txhaj tshuaj subcutaneous, phenol thiab zinc diffuse tam sim ntawd. Cov ua - nyob rau hauv electrostatic repulsion yuam lub hexamer tam sim ntawd tawg mus rau hauv dimers thiab ces tam sim ntawd mus rau hauv active monomers.
Instantaneous Capillary Absorption
Vim tias kev hloov pauv ntawm hexamer mus rau monomer tshwm sim nyob rau hauv feeb ntau dua li cov xuab moos, cov tshuaj insulin molecules nrawm nrawm hla cov kab mob endothelial ntawm cov hlab ntsha hauv zos. Qhov no tso cai rau Insulin Aspart kom ncav cuag qhov siab tshaj plaws ntawm cov ntshav qabzib tsawg dua li ob zaug nrawm dua li Cov Tib Neeg Cov Tshuaj Insulin, ua tiav qhov kev xav ntawm lub cev thaum ntxov -theem insulin tso tawm yuav tsum tau ua kom tsis txhob muaj qabzib tom qab taug kev.
2. Forensic Formulation Matrix: Aspart vs. Regular Human Insulin
Rau cov pab pawg muag tshuaj thiab cov kws tsim tshuaj kho mob, kev hloov pauv ntawm tib neeg cov tshuaj insulin mus sai sai - ua yeeb yam analogues hloov pauv cov lus qhia noj, pib lub sijhawm, thiab twj tso kua mis sib haum. Nkag siab txog cov tshuaj pharmacokinetic sib txawv no tsis yog - sib tham.
| Pharmacokinetic Parameter | Tib neeg Insulin (RHI) | Xi'an Tihealth Aspart API (CAS 116094-23-6) |
|---|---|---|
| Pib ntawm Kev Ua Haujlwm | 30 mus rau 60 feeb | 10 mus rau 20 feeb (Ultra-Rapid) |
| Peak Efficacy Qhov rai | 2 mus rau 4 teev tom qab- txhaj | 1 mus rau 3 xuab moos (Matches digestion nkhaus) |
| Lub Sijhawm Ua Haujlwm | 6 mus rau 8 teev (Kev pheej hmoo siab ntawm kev mob ntshav qab zib tsis txaus) | 3 mus rau 5 xuab moos (kev tshem tawm sai) |
| Dosing Timing | Yuav tsum tau noj 30-45 feeb ua ntej noj mov | Kev tswj tam sim ua ntej, lossis txawm tias thaum noj mov |
3. Lub Xi'an Tihealth Advantage: Precision Recombinant Manufacturing
Kev sib xyaw ua ke 51-amino acid analogue nrog kev hloov pauv tshwj xeeb yog ua tsis tau ntawm cov tshuaj organic ib txwm muaj. Nws yuav tsum tau sophisticated recombinant DNA technology siv xws li * Saccharomyces cerevisiae * los yog * Escherichia coli *. Cov chaw soj ntsuam dav dav sim ua cov txheej txheem no nquag tawm tsam nrog qhov tseeb disulfide daim ntawv cog lus folding, ua rau muaj qib siab ntawm immunogenic High Molecular Weight Polymers (HMWP), desamido-insulin impurities, thiab host-cell protein paug.
NtawmXi'an Tihealth Biotechnology Co., Ltd., peb ua raws li kev soj ntsuam nruj me ntsis ntawm bio-fermentation thiab purification raws tu qauv tsim los lav cov qauv kev ncaj ncees thiab kev nyab xeeb ntawm parenteral:
Vector Precision & Refolding
Peb cov txheej txheem recombinant xyuas kom meej qhov chaw ntawm aspartic acid ntawm txoj hauj lwm B28. Tom qab fermentation, lub precursor peptide tau txais kev tswj hwm kev ua kom muaj zog ntawm cov enzymatic cleavage thiab muaj tswv cuab hauv -vitro refolding txheej txheem. Qhov no ua kom tag nrho peb qhov tseem ceeb ntawm kev sib txuas ntawm disulfide ua tib zoo nrog tib neeg insulin geometry, ua kom tag nrho cov kev ua haujlwm lom neeg.
Multi-Dimensional Prep-HPLC
Fermentation broth inevitably muaj kab mob -cov proteins ntawm tes thiab misfolded variants. Peb lub chaw ua haujlwm leverages industrial-scale Preparative High-Performance Liquid Chromatography (Prep-HPLC) nrog optimized gradient elution kom cais cov Insulin Aspart macromolecule tseeb, tsav tsheb purity qib dhau los.Ntau dua lossis sib npaug li 99.0%.
Kev tswj hwm nruj Endotoxin
Vim tias Insulin Aspart yog tsim tshwj xeeb rau subcutaneous, tso dej, lossis kev tswj hwm twj tso kua mis tas mus li, kev kis kab mob lom yog qhov tseem ceeb tsis ua haujlwm. Peb API crystallization thiab lyophilization tshwm sim nyob rau hauv ISO Class 5 cleanrooms, kom ntseeg tau tias cov kab mob endotoxins nyob twj ywm nruj me ntsis hauv qab pharmacopeial txwv.
4. Muaj Scenarios rau Insulin Aspart Formulations
Qhov kev coj dawb huv thiab kev kwv yees tsis sib xws ntawm peb cov Insulin Aspart API tso cai rau nws mus siv thoob plaws cov txheej txheem thev naus laus zis tshaj plaws hauv kev kho mob ntshav qab zib niaj hnub:
Nruam Subcutaneous Insulin Infusion (CSII) Pumps
Insulin Aspart yog qhov zoo tshaj plaws analogue rau niaj hnub, kaw -loop "artificial pancreas" twj tshuab. Peb API ua kom pom qhov tshwj xeeb ntawm lub cev ruaj khov nyob rau hauv qhov tsis tu ncua txhua yam agitation thiab siab lub cev kub, tiv thaiv lub twj tso kua mis occlusion los yog catheter blockages los ntawm protein fibrillation.
Advanced Co-Cov qauv tsim (xws li Aspart + Degludec)
Vim tias Aspart tswj kev ruaj ntseg ntawm lub cev pH, nws tuaj yeem ua tiav co-formulated hauv ib lub vial lossis cwj mem nrog ultra-ntev- ua yeeb yam basals zoo li Insulin Degludec yam tsis tsim cov tsis xav tau hybrid hexamers, xa ob qho tib si basal thiab prandial kev pab cuam hauv ib qho kev txhaj tshuaj.
Formulator & Procurement FAQ
Txawm hais tias nws qhov kev tsim kho tsis zoo, Aspart yuav tsum nyob ruaj khov hauv lub vial lossis cartridge ntev txog 2 xyoos. Formulators ua tiav qhov no los ntawm complexing API nrog cov molar piv ntawm Zinc (Zn2+) thiab phenolic preservatives (xws li phenol thiab meta-cresol). Cov excipients lub cev quab yuam cov repelling monomers rau hauv lub xeev hexameric dormant. Thaum txhaj tshuaj, cov ntaub so ntswg sai sai tshem tawm cov phenol thiab zinc, unleashing lub npaj monomeric cascade.
Macromolecular peptides raug thermal degradation sai thiab fibrillation yog mishandled. Ua raws li peb cov txheej txheem lyophilization siab heev, qhuav API hmoov tam sim ntawd ntim rau hauv tsis muaj menyuam, tshuaj - qib kaw vials lossis ob npaug - txheej aseptic aluminium ntawv ci hnab nyob rau hauv ib qho inert gas flush. Kev thauj khoom thoob ntiaj teb yog tswj hwm tshwj xeeb ntawm kev txias txias-chain logistics (tshem ntawm 2℃txog 8 degree), siv qhov kub thiab txias tsis tu ncua- taug qab cov ntaub ntawv loggers kom lav cov qauv kev ntseeg siab thaum tuaj txog.
Yog lawm. Ua haujlwm raws li ISO9001: 2015 cov txheej txheem nruj, Xi'an Tihealth muab cov txheej txheem kev qhia dav dav nrog txhua qhov xa tawm. Qhov no suav nrog Daim Ntawv Pov Thawj Zoo Kev Ntsuam Xyuas (COA), siab - daws teeb meem HPLC chromatograms lees paub lub hom phiaj purity thiab impurity cais, thiab nruj kab mob endotoxin cov ntaub ntawv, streamlining koj downstream R&D validation thiab tswj cov txheej txheem zoo.
Ua kom koj cov kav dej kho mob nrawm nrog ultra- ntshiab, nrawm- ua kom rov ua dua peptide APIs.
Thov HPLC Chromatogram & Bulk PricingSau los ntawm Wang Xueyan, Technical Operations & Formulation Strategy ntawm Xi'an Tihealth Biotechnology Co., Ltd.
* Kev lees paub tsis raug cai: Muab tshwj xeeb raws li qhov tsis muaj npe, tshawb fawb -qib Cov Khoom Siv Tshuaj (API). Cov koom haum yuav khoom tsuas yog lub luag haujlwm rau kev tsim kho zaum kawg, kev sim tshuaj ntsuam xyuas, kev nyab xeeb sib xyaw, thiab kev tswj hwm nruj hauv lawv txoj cai thoob ntiaj teb.*
Xa kev nug